FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. EKRA Issue.

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. S&G Labs has no contractual relationships with the entities that referred clients to S&G Labs. EKRA Issue.

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

BMJ

MAY 10, 2022

Introductory article to İkİIşik H, Sezerol MA, Taşçı Y, et alCOVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: a cross-sectional study from TurkeyFamily Medicine and Community Health 2022;10:e001430. COVID-19 diagnosis of self Yes 24 (44.4) Immunization, 2019.

Vaccination 40

Vaccination Healthcare Professional Healthcare Primary Care 40

GeriPal

FEBRUARY 27, 2025

But back in 2019, there was a lot of disagreement in our group about whether for a patient with cancer and cancer related pain and a substance use disorder, whether palliative care was the appropriate specialty to care for those patients. Widera and Smith have no relationships to disclose. And I see everybody’s nodding to that.

Patients 74

Patients Clinic Patient-Centered Illness 74